Publication | Open Access

Gadolinium-based contrast agents: Stimulators of myeloid-induced renal fibrosis and major metabolic disruptors

Gadolinium-based Contrast AgentsMyeloid-induced Renal FibrosisUrologyEngineeringRenal FunctionMedicineImaging AgentMolecular ImagingMajor Metabolic DisruptorsVascular BiologyBiomedical EngineeringContrast AgentChronic Kidney DiseaseRenal PharmacologyNephrologyKidney Research